Get the latest news about Obliteride 2020 from Director Jim Birrell.

read more
Log In
  • About
  • News and Media

Obliteride media resources

A news interview being conducted as Gas Works Park

Fred Hutch Obliteride is the largest and best-organized fundraising bike ride and 5K walk/run in the Pacific Northwest. We’re a movement to obliterate cancer by fueling lifesaving research at Fred Hutchinson Cancer Research Center in Seattle. For 2020, we reimagined our event so that our participants could pick any activity and have fun from a safe distance. The final day of our season was Saturday, August 8.

Media contact:
Kerri Kazarba Schneider
206.288.3332
kerri@obliteride.org

Obliteride media coverage

We love it when people share news about our event and community. Check out some of our recent coverage. 

Press Release

Fred Hutch Obliteride raises more than $3 million in 2020

Fundraising exceeds organizers’ expectations in unprecedented pandemic era.

Read more
King 5 News

'Obliteride' seeing record turnout despite going virtual amid pandemic

Participants around the world are raising money for cancer and COVID-19 research through the Fred Hutchinson Cancer Research Center.

See more
King 5 News

Seattle skyline glows orange to support national cancer research at Fred Hutch

Despite this year being a virtual event, sign-up numbers are at an all-time high, according to the organization.

Read more
Puget Sound Business Journal

Fred Hutch Obliteride 2019 raises more than $2.5 million

Some 2,489 enthusiastic people hooted and cheered Saturday as they participated in the 7th annual Fred Hutch Obliteride fundraiser ...

Read more
Media resources

Selected photos and media fact sheet

View and download photos approved for articles and media, or download our one-page overview of Obliteride and Fred Hutchinson Cancer Research Center.

View photos Media fact sheet
An illustration of a man on a bicycle wearing an Obliteride jersey.

Learn more

Discover how Obliteride is helping Fred Hutch cure cancer faster.

Where the Money Goes
What Is Obliteride?